LEMD1 and colorectal cancer: LINC00958 might promote colorectal cancer progression by repressing the effect of miR-3064-5p on LEMD1 to activate the PI3K/AKT signaling pathway; this may potentially provide therapeutic targets for patients with colorectal cancer.